A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

Kissei logo

Kissei

Status and phase

Completed
Phase 2

Conditions

Endometriosis

Treatments

Drug: KLH-2109

Study type

Interventional

Funder types

Industry

Identifiers

NCT01395940
KLH1201

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.

Enrollment

20 estimated patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Female patients with endometriosis

Exclusion criteria

Patients with clinically significant hepatic, renal, or cardiovascular dysfunction

Trial design

20 participants in 2 patient groups

KLH-2109, lower dose
Experimental group
Treatment:
Drug: KLH-2109
KLH-2109, higher dose
Experimental group
Treatment:
Drug: KLH-2109

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems